Overview

FDA Approved Medication to Reduce Binge Eating and/or Purging

Status:
Completed
Trial end date:
2017-04-15
Target enrollment:
Participant gender:
Summary
This study will demonstrate the efficacy of Qsymia versus placebo in treating bulimia nervosa and binge eating disorder.
Phase:
Phase 1
Details
Lead Sponsor:
Stanford University
Treatments:
Phentermine
Topiramate